drugset / Trial / NCT01302158

Drug-drug Interaction Study With ASP1941 and Glimepiride

NCT01302158

Phase 1 Completed 52 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-labelBasic science

Summary

A study to investigate the effect of ASP1941 on the pharmacokinetics and safety of glimepiride (Part A) and to investigate the effect of glimepiride on the pharmacokinetics, safety and pharmacodynamics of ASP1941 (Part B).

Timeline

Start
2009-12
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule Oral
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.